Delivery Order SPE2DB22D1103-SPE2DB25FTRK5
Award Date 7/9/25
Potential Completion Date 7/10/25
Potential Value $1.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of lisdexamfetamine 20 mg capsules. The contract has a ceiling value of $2,853.76 and a completion date of July 9, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical, which provides a comprehensive...
- This is a $2,140.32 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,566,979,063 units of 30mg lisdexamfetamine capsules, a prescription medication. The contract has an ultimate completion date of January 21, 2025 and was awarded on January 17, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,704.52, is for the supply of lisdexamfetamine 30 mg capsules in 100-count bottles. The contract is a firm-fixed-price delivery order with an ultimate completion date of January 28, 2025. This contract award is not associated with a set-aside program and is part of a larger Indefinite...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,287.68, is for the delivery of 4,567,956,474 units of the prescription medication lisdexamfetamine 40 mg capsules. The contract is a firm fixed-price, non-set-aside arrangement with an ultimate completion date of April 18, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This is a $6,298.54 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for the drug Lisdexamfetamine 40 mg capsules, a medication used to treat conditions such as attention deficit hyperactivity disorder (ADHD). The delivery order has an ultimate completion date of July 14, 2025 and is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a larger...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lisdexamfetamine 40 mg capsules. The award, valued at $4,144.08, has an ultimate completion date of July 3, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 100 capsules of the prescription drug lisdexamfetamine 20 mg, with a ceiling value of $2,922.77 and a completion date of June 24, 2025. This award is not designated as a set-aside contract. The contract is part of a larger $999,999,999.00 Indefinite Delivery...
- This is a $1,254.83 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 100 units of the medication lisdexamfetamine 30 mg capsules. The contract has a performance period ending on June 12, 2025 and does not utilize a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 100 units of the prescription medication Lisdexamfetamine 40 mg capsules. The contract has a firm fixed price of $18,118.64 and a performance period ending on June 18, 2025. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,539.16, is for the delivery of 4,567,420,917 units of the prescription drug lisdexamfetamine 40 mg capsules. The contract has a period of performance through March 3, 2025 and is a firm fixed-price contract. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB25FTRK5Delivery Order
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply Lisdexamfetamine 40 mg capsules. The $1,293.14 contract has an ultimate completion date of July 10, 2025. The award is not set aside for any specific business classification. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides comprehensive global pharmaceutical support to military healthcare programs and other government agencies through December 2026.
Generated 10/8/25, 10:51 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 7/9/25 |